ResMed Inc.
RMDNYSEHealthcare● Active
$196.04
+$1.72(+0.89%)
Market Cap$28.4B
P/E Ratio—
52W High$293.81
52W Low$180.27
ResMed Inc. (RMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RMD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.15B | $4.69B | $4.22B | $3.58B | $3.20B |
| Cost of Revenue | $2.09B | $2.03B | $1.87B | $1.55B | $1.36B |
| Gross Profit | $3.05B | $2.66B | $2.36B | $2.02B | $1.84B |
| Gross Margin %(computed) | 59.36% | 56.67% | 55.78% | 56.57% | 57.53% |
| Operating Expenses | |||||
| R&D Expenses | $0.33B | $0.31B | $0.29B | $0.25B | $0.23B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.37B | $1.34B | $1.22B | $1.02B | $0.94B |
| Operating Income | $1.69B | $1.32B | $1.13B | $1.00B | $0.90B |
| Operating Margin %(computed) | 32.75% | 28.17% | 26.80% | 27.96% | 28.27% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.05B | $0.05B | $0.02B | $0.02B |
| Income Before Tax | $1.68B | $1.26B | $1.10B | $0.96B | $0.88B |
| Income Tax Expense | $0.28B | $0.24B | $0.20B | $0.18B | $0.41B |
| Net Income | $1.40B | $1.02B | $0.90B | $0.78B | $0.47B |
| Net Margin %(computed) | 27.22% | 21.79% | 21.25% | 21.78% | 14.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $9.55 | $6.94 | $6.12 | $5.34 | $3.27 |
| Wtd Avg Shares | 0.15B | 0.15B | 0.15B | 0.15B | 0.15B |
| EBITDA | $1.91B | $1.53B | $1.36B | $1.18B | $1.10B |
| EBITDA Margin %(computed) | 37.18% | 32.73% | 32.18% | 32.88% | 34.53% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more ResMed Inc. data
About ResMed Inc. (RMD) Income Statement
ResMed Inc. (RMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RMD reported revenue of $5.15B, gross profit of $3.05B (gross margin 59.36%), and net income of $1.40B — a net profit margin of 27.22%.
Frequently asked questions
RMD · 4 questionsResMed Inc. (RMD) reported revenue of $5.15B for 2025, up 9.8% year-over-year.
RMD revenueRMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08